COVID-19
The 17 experts recently dismissed from the Advisory Committee on Immunization Practices, a panel that guides US vaccine policy, have published an essay criticizing US Health Secretary Robert F. Kennedy Jr.'s "destabilizing decisions" that may lead to more preventable disease spread. The experts, who were removed
COVID-19
Research published in JAMA Network Open reveals that alcohol-associated liver disease (ALD) mortality has more than doubled between 1999 and 2022, with significant acceleration from 2018 to 2022. This disturbing trend disproportionately affects women, young adults, and American Indian and Alaskan Native populations. The study highlights the need for targeted
COVID-19
A recent study has shed light on the risks associated with COVID-19 in pregnant women, showing a significant increase in complications and mortality rates compared to non-infected women. The research, conducted in Spain between 2020 and 2022, found that women with COVID-19 at the time of childbirth had a longer
COVID-19
A U.S. District Court for the District of Rhode Island has granted a motion for a preliminary injunction against the Department of Health and Human Services (HHS) and Secretary of Health and Human Services, Robert F. Kennedy Jr. This ruling comes after HHS unilaterally terminated access to $11 billion
COVID-19
In a new study published in Current Issues in Molecular Biology, researchers at London Metropolitan University have discovered that rhamnolipids, a type of nanomicelle, exhibit potent antiviral activity against rhinovirus, a common cause of hospital-acquired infections. The study, led by Lila Touabi, highlights the potential of rhamnolipids as an alternative
COVID-19
Children have been surprisingly resilient against the COVID-19 virus, with many experiencing mild or asymptomatic disease, and most recovering without specific therapy. However, severe disease can occur, and risk factors for hospitalization and death have been identified. A recent study from the University of Utah has shed light on the
COVID-19
New research from Sapienza University of Rome, Italy, has found that SARS-CoV-2 infection in children can lead to significant kidney damage, characterized by hyperfiltration, proteinuria, and hematuria. The study, published in the journal Microorganisms, retrospectively evaluated renal function in 148 children who had previously contracted the virus. The findings suggest
COVID-19
A new report from researchers in China highlights the effectiveness of wastewater-based epidemiology (WBE) in monitoring and predicting the spread of COVID-19. The study, conducted by a team from the Chinese Academy of Sciences, used antipyretic concentrations in wastewater to estimate the number of individuals with fever and incorporated this
COVID-19
According to a recent study published in the AJPM Focus journal, the COVID-19 pandemic has had a differential impact on cigarette smoking habits across racial and ethnic groups in adults with chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma. The study analyzed data from 10,763
COVID-19
Research on supply chain logistics has shed light on the pressing need for accurate and effective identification of threats to prevent vulnerability in food supply and security, particularly in the wake of global events such as the COVID-19 pandemic, wars, and climate change. A study conducted by researchers at Malek
COVID-19
Social lockdowns and quarantines have been enforced in various populations to mitigate the spread of coronavirus disease 2019 (COVID-19) in the community. A recent study published in the Singapore Medical Journal investigated the impact of COVID-19 lockdown, known as circuit breaker movement restrictions (CBMR), on physical activity (PA) and sedentary
COVID-19
Researchers at the University of Cambridge have conducted a comprehensive review of Moderna's mRNA-1083 and Pfizer/BioNTech's mRNA-1020/1030 dual-target vaccines for COVID-19 and influenza. The study found that both vaccines utilize mRNA technology, demonstrating strong immunogenicity and favorable safety profiles. Moderna's mRNA-1083 showed
